Skip to content
Income Statement · TASI 8050

Salama Cooperative Insurance Co.
Revenue history.

Income generated from the company’s principal activities before expenses. Explore 20 reported observations from 2018 to 2022, with every value linked to its official evidence.

Coverage2018–202220 source-linked periods
Annual history5annual reporting periods
Interim history15quarterly or year-to-date periods
StatementIncome Statementas reported by the issuer
Annual series

Revenue

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Revenue544.57M SAR
Revenue0200M400M600M20182019202020212022
Hover or tap to exploreSAR
First-quarter series

Revenue

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Revenue2.52M SAR
Revenue-4M-2M02M4M6M8M20182019202020212022
Hover or tap to exploreSAR
Half-year series

Revenue

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Revenue2.88M SAR
Revenue-2M02M4M6M8M20182019202020212022
Hover or tap to exploreSAR
Nine-month series

Revenue

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Revenue2.19M SAR
Revenue02.5M5M7.5M10M12.5M20182019202020212022
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
FY 20222022-12-31544,567Year ended 31 December 2022544.57M SARTOTAL REVENUESOfficial p. 9 ↗Open statement →
9M / Q3 20222022-09-302,1852022-01-01 to 2022-09-302.19M SARTotal revenueOfficial p. 6 ↗Open statement →
H1 / Q2 20222022-06-302,8832022-01-01 to 2022-06-302.88M SARTotal revenueOfficial source ↗Open statement →
Q1 20222022-03-312,5162022-01-01 to 2022-03-312.52M SARTotal revenueOfficial source ↗Open statement →
FY 20212021-12-3112,6012021-01-01 to 2021-12-3112.6M SARTotal revenueOfficial source ↗Open statement →
9M / Q3 20212021-09-3011,5582021-01-01 to 2021-09-3011.56M SARTotal revenueOfficial source ↗Open statement →
H1 / Q2 20212021-06-307,4052021-01-01 to 2021-06-307.41M SARTotal revenueOfficial source ↗Open statement →
Q1 20212021-03-313,6182021-01-01 to 2021-03-313.62M SARTotal revenueOfficial source ↗Open statement →
FY 20202020-12-315,9952020-01-01 to 2020-12-316M SARTotal revenueOfficial source ↗Open statement →
9M / Q3 20202020-09-304,1592020-01-01 to 2020-09-304.16M SARTotal revenueOfficial source ↗Open statement →
H1 / Q2 20202020-06-30-1962020-01-01 to 2020-06-30−196K SARTotal revenueOfficial source ↗Open statement →
Q1 20202020-03-31-2,0402020-01-01 to 2020-03-31−2.04M SARTotal revenueOfficial source ↗Open statement →
FY 20192019-12-3110,0862019-01-01 to 2019-12-3110.09M SARTotal revenueOfficial source ↗Open statement →
9M / Q3 20192019-09-307,0772019-01-01 to 2019-09-307.08M SARTotal revenueOfficial source ↗Open statement →
H1 / Q2 20192019-06-307,9822019-01-01 to 2019-06-307.98M SARTotal revenueOfficial source ↗Open statement →
Q1 20192019-03-316,7772019-01-01 to 2019-03-316.78M SARTotal revenueOfficial source ↗Open statement →
FY 20182018-12-316,7942018-01-01 to 2018-12-316.79M SARTotal revenueOfficial source ↗Open statement →
9M / Q3 20182018-09-305,8652018-01-01 to 2018-09-305.87M SARTotal revenueOfficial source ↗Open statement →
H1 / Q2 20182018-06-304,9172018-01-01 to 2018-06-304.92M SARTotal revenueOfficial source ↗Open statement →
Q1 20182018-03-314,1182018-01-01 to 2018-03-314.12M SARTotal revenueOfficial source ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

سلامة — Revenue

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.